Asia Pacific Haemostatic Agents Market By Type (Thrombin Based Haemostats, Gelatin Based Haemostats, Collagen Based Haemostats, Oxidized Regenerated Cellulose Based Haemostats, Combination Haemostats, Fibrin Sealants And Others), By Treatment (Cardiovascular, General Surgery, Digestive Surgery, Neurosurgery And Others), By End User (Hospitals, Surgery Centres, Nursing Homes And Others), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Asia Pacific Haemostatic Agents Market By Type (Thrombin Based Haemostats, Gelatin Based Haemostats, Collagen Based Haemostats, Oxidized Regenerated Cellulose Based Haemostats, Combination Haemostats, Fibrin Sealants And Others), By Treatment (Cardiovascular, General Surgery, Digestive Surgery, Neurosurgery And Others), By End User (Hospitals, Surgery Centres, Nursing Homes And Others), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 4532 | Pages: 185 | November 2017 | Region: Asia Pacific


According to the Asia Pacific Haemostatic Agents Market Research Report, the market was worth USD X.XX billion in 2016 and estimated to be growing at a CAGR of XX.XX%, to reach USD XX.XX billion by 2021. Haemostatic Agents refers to the class of substances that are usually used to promote haemostasis or to stop bleeding. Haemostats are the technical term given to instruments used to reduce or halt bleeding during a surgical procedure.

The major technological advancements in the field have increased the usage of haemostats in surgical procedures in recent times. Common problems faced by haemostats include tissue contamination and ease of usage. These have been addressed in the latest wave of innovations

The major factors affecting the Haemostatic Agents market include the rising prevalence of diseases and rising awareness regarding latest medical practices. Other drivers include increasing health consciousness among consumers, use of new inventions and enhanced technologies. As for the restraints of the market, the high costs and the unfavourable reimbursement policies are the major hurdles. This along with the fact that people are not aware of the latest developments in developing and underdeveloped countries restrain the market growth.

Asia Pacific Haemostatic Agents market Segmentation by Type into Thrombin Based Haemostats, Gelatin Based Haemostats, Collagen Based Haemostats, Oxidized Regenerated Cellulose Based Haemostats, Combination Haemostats, Fibrin Sealants and Others, by Treatment into Cardiovascular, General Surgery, Digestive Surgery, Neurosurgery and Others, and based on End User into Hospitals, Surgery Centres, Nursing Homes and Others. Based on geography, the Asia-Pacific market is divided into India, China, South Korea, Japan and Australia. Asia-Pacific is expected to grow rapidly in the coming years as is evident from the high CAGR value for the region. In addition to having the highest growth rate, the region also has the third highest market share. The rapid growth of the region can be attributed to the developing stature of countries such as India and China.

The Haemostatic Agents market is highly competitive with a large number of players. Haemostatic Agents Industry Key players dominating the market with their products and services are Ethicon, Pfizer, Baxter International, R. Bard, The Medicines Company, Anika Therapeutics, Advanced Medical Solutions, Integra LifeSciences, B Braun Melsungen, Gelita Medical, Equimedical, Vascular Solutions, Marine Polymer Technologies and Z-Medica.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Thrombin Based Haemostats          

                                5.1.3 Gelatin Based Haemostats               

                                5.1.4 Collagen Based Haemostats            

                                5.1.5 Oxidized Regenerated Cellulose Based Haemostats             

                                5.1.6 Combination Haemostats 

                                5.1.7 Fibrin Sealants       

                                5.1.8 Others      

                                5.1.9  Y-o-Y Growth Analysis, By Type    

                                5.1.10  Market Attractiveness Analysis, By Type                

                                5.1.11  Market Share Analysis, By Type  

                5.2 Treatment                  

                                5.2.1 Introduction           

                                5.2.2 Cardiovascular       

                                5.2.3 General Surgery   

                                5.2.4 Digestive Surgery 

                                5.2.5 Neurosurgery        

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Treatment          

                                5.2.8 Market Attractiveness Analysis, By Treatment        

                                5.2.9 Market Share Analysis, By Treatment         

                5.3 End User                      

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Surgery Centres    

                                5.3.4 Nursing Homes     

                                5.3.5 Others      

                                5.3.6 Y-o-Y Growth Analysis, By End User             

                                5.3.7  Market Attractiveness Analysis, By End User          

                                5.3.8  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By Treatment

                                                6.1.3.4 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By Treatment

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By Treatment

                                                6.1.5.4 By End User

                6.2 China                             

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea                               

                6.6 Australia                      

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Ethicon                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer                            

                8.3 Baxter International                               

                8.4 R. Bard                          

                8.5 The Medicines Company                      

                8.6 Anika Therapeutics                 

                8.7 Advanced Medical Solutions                               

                8.8 Integra Life Sciences                               

                8.9 Gelita Medical                           

                8.10 Z-Medica                   

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms by type, packaging and meat type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the North america market; which includes broadly demographic, economic and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific Haemostatic Agents Market By Type, From 2016-2021 ( USD Million )
  2. Asia Pacific Thrombin Based Market By Region, From 2016-2021 ( USD Million )
  3. Asia Pacific Gelatin Based Market By Region, From 2016-2021 ( USD Million )
  4. Asia Pacific Collagen Based Market By Region, From 2016-2021 ( USD Million )
  5. Asia Pacific Oxidized Regenerated Cellulose Based Market By Region, From 2016-2021 ( USD Million )
  6. Asia Pacific Combination Haemostats Market By Region, From 2016-2021 ( USD Million )
  7. Asia Pacific Fibrin Sealants Market By Region, From 2016-2021 ( USD Million )
  8. Asia Pacific Others Market By Region, From 2016-2021 ( USD Million )
  9. Asia Pacific Haemostatic Agents Market By Treatment, From 2016-2021 ( USD Million )
  10. Asia Pacific Cardiovascular Market By Region, From 2016-2021 ( USD Million )
  11. Asia Pacific General Surgery Market By Region, From 2016-2021 ( USD Million )
  12. Asia Pacific Digestive Surgery Market By Region, From 2016-2021 ( USD Million )
  13. Asia Pacific Neurosurgery Market By Region, From 2016-2021 ( USD Million )
  14. Asia Pacific Others Market By Region, From 2016-2021 ( USD Million )
  15. Asia Pacific Haemostatic Agents Market By End Users, From 2016-2021 ( USD Million )
  16. Asia Pacific Hospitals Market By Region, From 2016-2021 ( USD Million )
  17. Asia Pacific Surgery Centres Market By Region, From 2016-2021 ( USD Million )
  18. Asia Pacific Nursing Homes Market By Region, From 2016-2021 ( USD Million )
  19. Asia Pacific Others Market By Region, From 2016-2021 ( USD Million )
  20. Japan Haemostatic Agents Market By Type, From 2016-2021 ( USD Million )
  21. Japan Haemostatic Agents Market By Treatment, From 2016-2021 ( USD Million )
  22. Japan Haemostatic Agents Market By End Users, From 2016-2021 ( USD Million )
  23. China Haemostatic Agents Market By Type, From 2016-2021 ( USD Million )
  24. China Haemostatic Agents Market By Treatment, From 2016-2021 ( USD Million )
  25. China Haemostatic Agents Market By End Users, From 2016-2021 ( USD Million )
  26. India Haemostatic Agents Market By Type, From 2016-2021 ( USD Million )
  27. India Haemostatic Agents Market By Treatment, From 2016-2021 ( USD Million )
  28. India Haemostatic Agents Market By End Users, From 2016-2021 ( USD Million )
  29. Australia Haemostatic Agents Market By Type, From 2016-2021 ( USD Million )
  30. Australia Haemostatic Agents Market By Treatment, From 2016-2021 ( USD Million )
  31. Australia Haemostatic Agents Market By End Users, From 2016-2021 ( USD Million )
  32. South Korea Haemostatic Agents Market By Type, From 2016-2021 ( USD Million )
  33. South Korea Haemostatic Agents Market By Treatment, From 2016-2021 ( USD Million )
  34. South Korea Haemostatic Agents Market By End Users, From 2016-2021 ( USD Million )
Middle East And Africa Infant Incubator Market By Product (Transport Infant Incubator And Neonatal Intensive Care Unit (NICU) Incubator), By Application (Neonatal Hypothermia, Lower Birth Weight, Genetic Defects, An...
Latin America Infant Incubator Market By Product (Transport Infant Incubator And Neonatal Intensive Care Unit (NICU) Incubator), By Application (Neonatal Hypothermia, Lower Birth Weight, Genetic Defects, And Others)...
Asia Pacific Infant Incubator Market By Product (Transport Infant Incubator And Neonatal Intensive Care Unit (NICU) Incubator), By Application (Neonatal Hypothermia, Lower Birth Weight, Genetic Defects, And Others),...
Europe Infant Incubator Market Product (Transport Infant Incubator And Neonatal Intensive Care Unit (NICU) Incubator), By Application (Neonatal Hypothermia, Lower Birth Weight, Genetic Defects, And Others), And By R...
North America Infant Incubator Market By Product (Transport Infant Incubator And Neonatal Intensive Care Unit (NICU) Incubator), By Application (Neonatal Hypothermia, Lower Birth Weight, Genetic Defects, And Others)...
Infant Incubator Market By Product (Transport Infant Incubator And Neonatal Intensive Care Unit (NICU) Incubator), By Application (Neonatal Hypothermia, Lower Birth Weight, Genetic Defects, And Others), And By Regio...
Middle East And Africa Vascular Guidewires Market By Product (Coronary Guidewires And Peripheral Guidewires), By Coating Type (Coated, And Non-Coated), And By End User (Hospitals And Ambulatory Surgical Centers (AS...
Latin America Vascular Guidewires Market By Product (Coronary Guidewires And Peripheral Guidewires), By Coating Type (Coated, And Non-Coated), And By End User (Hospitals And Ambulatory Surgical Centers (ASCs)) And ...
Asia Pacific Vascular Guidewires Market By Product (Coronary Guidewires And Peripheral Guidewires), By Coating Type (Coated, And Non-Coated), And By End User (Hospitals And Ambulatory Surgical Centers (ASCs)) And B...
Europe Vascular Guidewires Market By Product (Coronary Guidewires And Peripheral Guidewires), By Coating Type (Coated, And Non-Coated), And By End User (Hospitals And Ambulatory Surgical Centers (ASCs)) And By Regi...
North America Vascular Guidewires Market By Product (Coronary Guidewires And Peripheral Guidewires), By Coating Type (Coated, And Non-Coated), And By End User (Hospitals And Ambulatory Surgical Centers (ASCs)) And ...
Vascular Guidewires Market By Product (Coronary Guidewires And Peripheral Guidewires), By Coating Type (Coated, And Non-Coated), And By End User (Hospitals And Ambulatory Surgical Centers (ASCs)) And By Region - Gl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.